N-[(2R,S)-2,3-Dihydroxypropyl-d5]-3-[(2-fluoro-4-iodophenyl)aMino]-4-pyridinecarboxaMide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(,N-[(2R,S)-2,3-Dihydroxypropyl-d5]-3-[(2-fluoro-4-iodophenyl)aMino]-4-pyridinecarboxaMide) Labelled AS703026 (A780100). AS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor, in human multiple myeloma (MM). AS703026 induces pleiotropic anti-myeloma activity in vitro and in vi vo. MEK inhibitors are useful in the treatment of hyperproliferative diseases, such as cancer, restenosis and inflammation.

N-[(2R,S)-2,3-Dihydroxypropyl-d5]-3-[(2-fluoro-4-iodophenyl)aMino]-4-pyridinecarboxaMide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-[(2R,S)-2,3-Dihydroxypropyl-d5]-3-[(2-fluoro-4-iodophenyl)aMino]-4-pyridinecarboxaMide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	45000	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58

---

• N-[(2R,S)-2,3-Dihydroxypropyl-d5]-3-[(2-fluoro-4-iodophenyl)aMino]-4-pyridinecarboxaMide
• rac-AS-703026-d5
• 1794960-29-4